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ABSTRACT 
INTRODUCTION:	
Tuberculosis (TB) is an important public health issue, but diagnosis in children can be 
challenging. The radiological hallmark of pulmonary TB (PTB) in children is mediastinal 
lymphadenopathy, however there is inter-observer variability in detecting this.  The value of 
the lateral CXR in addition to the frontal view to detect lymphadenopathy has not been well 
studied.  
 
OBJECTIVES:	
To investigate the prevalence of lymphadenopathy in children with confirmed PTB detected 
on frontal compared to frontal-lateral CXRs. 
	
METHODS:	
This was a secondary analysis of a study from Red Cross Children’s Hospital in Cape Town. 
Children with definite TB and a control group (Lower respiratory tract infection other than 
TB) who had frontal and lateral CXRs were included in this study. Three radiologists 
independently read the CXRs in 2 separate sittings  (frontal CXR and ‘combination frontal-
lateral’ CXR). A 3 reader consensus reading was used during data analysis. Odds ratios and 
95% confidence intervals were calculated to determine the presence of lymphadenopathy. 
Kappa statistics were calculated to determine inter reader agreement. 
 
RESULTS:	
Of 172 children (88 confirmed TB and 84 control children), with a median age of 29 months, 
lymphadenopathy was reported in 86 (50%) patients on the frontal CXR alone and in 143 
(83%) on the frontal-lateral CXR combination, p= 0.00. Amongst confirmed PTB cases, 52 
(60%) had lymphadenopathy on the frontal CXR alone while 72 (82%) had lymphadenopathy 
on the frontal-lateral CXR combination, p= 0.00.  Amongst the control group, 34 (40%) had 
lymphadenopathy on the frontal CXR alone while 71 (85%) had lymphadenopathy on the 
frontal-lateral CXR combination, p= 0.00.  
The consensus reading using a frontal-lateral CXR combination resulted in a 5 fold increase 
(OR 4,9; 95% CI 2,9-8,4) in diagnosis of lymphadenopathy compared to a frontal CXR only. 
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Overall inter reader agreement for all 3 readers was fair on both the frontal CXR (Kappa= 
0,21) and the frontal-lateral CXR (Kappa= 0,23) combination. 
 
CONCLUSION:	
The addition of a lateral view to the frontal CXR increased detection of lymphadenopathy, 
however, the prevalence of lymphadenopathy was similar in children with PTB and those in 
the control group, with fair inter reader agreement. 
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1.	Rationale		 	
In South Africa frontal and lateral chest X-rays (CXR) are often requested as baseline 
investigations in children with symptoms of lower respiratory tract infection (1, 2). Lateral 
CXRs are generally not recommended in addition to the frontal radiograph, as they do not 
substantially alter diagnosis or management of the patient, but increase radiation dose 
exposure (3-5). In South Africa, the burden of HIV and TB in children may result in a 
spectrum of CXR findings requiring reconsideration of the value of the lateral CXR (1, 2, 6-8, 
32). However lymphadenopathy, the cardinal sign of pulmonary TB (PTB) in children, may be 
more accurately diagnosed on lateral CXR.  Lateral CXRs are therefore frequently done in 
clinical practise when a diagnosis of PTB is suspected, to detect lymphadenopathy.  The 
value of lateral CXR in addition to the frontal view for detection of lymphadenopathy for 
suspected PTB in children has not been well studied (12,20,21). 
   
2.	Introduction	
Tuberculosis (TB) remains an important public health issue and causes serious morbidity and 
mortality. The Human Immunodeficiency Virus (HIV) epidemic has exacerbated the 
prevalence of TB and its complications (9, 10, 32). The risks of TB infection are more serious 
in children, especially those in the under 5-year age group, where there is a higher risk of 
spread and complications such as miliary TB or TB meningitis. Emphasis is therefore on early 
diagnosis and treatment (9). 
 
2.1.	TB	and	South	Africa	
South Africa has one of the highest prevalence rates of paediatric TB globally, with the 
childhood prevalence estimated to be more than 400 per 100 000 population per annum,  
(1, 8, 11, 12).The commonest form of TB disease in children is pulmonary TB (PTB). More 
severe disseminated disease such as TB meningitis may also occur in very young children or 
immunocompromised states, such as HIV or malnutrition, (1, 8). 
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2.2.	Diagnosis	of	TB	in	children.	
The diagnosis of PTB in children may be challenging as children present with non-specific 
symptoms and microbiologic confirmation may be difficult (11). This diagnostic challenge is 
increased in resource poor settings, such as sub Saharan Africa, as well as in settings of high 
HIV prevalence (8, 13, 14). In adults the gold standard for TB diagnosis is bacteriological 
confirmation, however microbiologic confirmation is not often performed in children due to 
the paucibacilliary nature of disease and lower bacteriological yields (6, 8).  
 
The diagnosis of PTB in children is therefore often made based on the clinical presenting 
features, TB contacts, the CXR findings as well as the tuberculin skin test with or without 
microbiologic confirmation. Children with associated HIV may have non-specific clinical 
symptoms and the tuberculin skin test may be falsely negative, making definitive diagnosis 
of PTB even more challenging (10, 13). Overall a microbiologically confirmed diagnosis of 
PTB is made in 30-50% of children with suspected PTB (2), even with the availability of rapid 
PCR testing (Xpert) (14). 
 
2.2.1.	CXR	and	TB	
The “radiological hallmark” in the diagnosis of PTB in children is the presence of mediastinal 
lymphadenopathy seen on CXR or Computed Tomography scan (CT) of the chest (10, 15-17). 
One of the five World Health Organization’s (WHO) diagnostic criteria for pulmonary TB in 
children includes “a suggestive appearance on chest radiograph” (11).  
CXR features in children with TB mimic the pathophysiology of the infection; these include 
additional radiological signs, such as compression of the airways by lymphadenopathy, a 
fine nodular pattern (miliary disease) or parenchymal cavitation on the X-ray (18, 19). 
 
Lymphadenopathy features on CXR are described as oval masses in the region of the hila on 
frontal projections and as a lobulated ring posterior to bronchus intermedius on lateral 
projections (20). The ‘doughnut sign’ is formed superoanteriorly by the aortic arch (its 
posterior aspect) and the right and left main pulmonary arteries, and inferiorly by hilar and 
subcarinal nodes. The centre of the doughnut sign is bronchus intermedius (19).  
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A CXR is recommended in the initial workup of children suspected of having PTB (31). While 
lymphadenopathy is the radiological hallmark of PTB on CXR, an important limitation is the 
wide inter- and intra observer variability, as reported in several studies (2, 11, 21). Studies 
by Swingler et al (18) and Lee et al (4) showed poorer inter-observer agreement when 
reading lateral CXRs compared to frontal films. The American Thoracic Society (ATS)/ Centre 
for Disease Control (CDC) guidelines, however, still recommend the use of a single frontal 
radiograph in all patients over the age of 5 years when screening for PTB, while children 
under this age should receive both a frontal and lateral radiograph (3, 22). Due to the high 
prevalence of PTB in South Africa most patients receive both a frontal and lateral radiograph 
as part of routine clinical care. The lateral projection is believed to increase the likelihood of 
visualizing lymphadenopathy and subsequently diagnosing PTB (2). The radiation risk of 
obtaining two projections in a child also needs to be considered. The dose received from a 
frontal CXR is 0,02mSv and from a lateral CXR is 0,04mSv; if a lateral projection is thus 
eliminated a dose reduction of approximately 67% can be achieved (5).  
 
Five studies were found in an English language literature search, which assessed the value of 
the lateral CXR compared to the frontal CXR in diagnosing PTB, summarised in Table 1. The 
study by Smuts et al included only children with signs and symptoms of PTB or those who 
had a positive TB contact. This study confirmed the usefulness of a lateral radiograph in 
diagnosing PTB in children, as evidenced by the 11% of cases with mediastinal 
lymphadenopathy found on lateral CXR only. This study had a large cohort of patients, but 
34 % of their study population consisted of clinic based patients with a positive TB contact, 
who had no symptoms of TB which cannot be extrapolated to studies of patients with 
confirmed TB (23).  
 
However another study (4), found no new abnormality detected on lateral CXR. This study 
was performed in a non-endemic area on asymptomatic patients, however, and these 
findings cannot be applied to patients living in TB endemic areas. None of the remaining 3 
studies (3, 5, 17) found any value in performing an additional lateral CXR for the diagnosis of 
PTB. The study by Swingler et al used CT scan of the chest as the gold standard for 
assessment of lymphadenopathy (18) and compared CXR interpretation. However, the CXR 
readers for this study included primary care physicians and paediatricians rather than 
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qualified radiologists, which may account for the poor inter-observer agreement with 
regards to interpretation of the lateral projection, compared with the frontal radiograph (5). 
The inclusion criteria of their patients were also those for suspected TB rather than 
confirmed TB, and even the CT gold standard quality at the time is questionable, given the 
poor CT inter-observer agreement (21). The studies by Eisenberg (5) and Meyer (3) were 
both done on an adult population with positive skin tuberculin tests. These studies were 
done in adults and therefore may not be comparable with a paediatric population, 
especially since the CXR features of pulmonary TB in adults are not characterised by 
lymphadenopathy (24).
Table	1:	Summary	of	studies	comparing	findings	on	lateral	and	frontal	chest	X-rays	in	suspected	PTB	
Study Demographics Diagnostic Inclusion Sample size Study Findings 
Smuts et al 
1994 
Children <12yrs   
Age range:  
1 month-12 years 
Symptoms of TB or a 
positive TB contact 
449  Lymphadenopathy visualized on: 
Frontal and lateral X-rays in 81 cases (18%) 
Frontal X-rays only in 29 cases (7%) 
Lateral X-rays only in 50 cases (11%) 
Swingler et al 
2005 
Children <14yrs  
Median age:  
21,5 months 
Suspected TB  100  “Use of AP together with lateral views showed a non-significant trend towards a 
higher diagnostic odds ratio than the use of the AP view alone or use of the 
lateral view alone.” 
Poorer inter-observer agreement for lateral views as compared to frontal views 
Lee et al 
2010 
Children ≤ 18yrs   
Mean age: 
10,8 ± 5,2 years 
Positive PPD skin test 
but no TB symptoms. 
605 No new abnormalities were noted on the lateral CXR compared to the frontal 
CXRs. 
Poorer inter-observer agreement in interpreting the lateral CXR compared to the 
frontal CXR 
 
Meyer 
2003 
Adults > 18yrs 
Mean age: 
39 ±15 years 
Positive tuberculin skin 
test 
 
535  
 
A new abnormality was noted on the lateral CXR in only 0,4% of cases.  
Abnormality did not alter patient management. 
Eisenberg et 
al 
2009 
Adults > 18yrs  
Mean age: 
Males: 38 ±11 years 
Females: 37 ± 11 
years 
Positive PPD test 875  No new abnormalities were noted on lateral CXR compared to frontal CXR.  
No change in management due to additional findings on lateral CXR 
16 
 
3.	Aim		
To investigate the prevalence of lymphadenopathy in children with proven PTB detected on 
frontal CXRs alone compared to frontal-lateral combination CXRs. 
  
4.	Study	Objectives	
- To determine and compare the prevalence of lymph nodes on frontal CXRs alone versus 
‘combination frontal-lateral’ set of CXRs in children with TB using patients with confirmed 
TB and comparing this to controls (children with LRTIs other than  TB). 
-To compare the prevalence of lymphadenopathy on frontal vs a frontal –lateral CXR 
combination by HIV status. 
 
5.	Methods	
5.1.	Research	paradigm	
Secondary analysis of data collected as part of a prospective study on improved diagnostic 
methods for childhood TB between 1 February 2009 to 31 December 2013. 
 
5.2.	Study	population	
The study population was all children diagnosed with definite TB (either through culture or 
Gene Xpert) at the Red Cross Children’s Hospital (RCCH) in Cape Town, South Africa, from 1 
February 2009 until 31 December 2013. A control group of patients included 84 children, 
who presented to RCCH with a lower respiratory tract infection other than TB 
(Classified as not TB, with a negative mantoux, no household TB contact and improved 
at months without TB treatment) from 1 February 2009 until 31 December 2013.  
 
5.2.1.	Inclusion	criteria	
The study group were children, less than 13 years of age, who presented to the RCCH and 
were diagnosed with PTB (confirmed on culture or Gene Xpert on induced sputum) who had 
both frontal and lateral CXRs prior to starting TB treatment.  
3  
17
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The control group were children (less than 13 years of age) who presented to RCCH with a 
lower respiratory tract infection other than TB (as defined above) who had both frontal and 
lateral CXRs. 
The CXRs were obtained from an existing database from the parent study, consisting of 
digital records of all the patient’s files (including a complete patient workup and diagnosis) 
and CXRs.  
 
5.2.2.	Exclusion	criteria	
Patients whose CXRs were of poor quality/unreadable as per customized report form (CRF). 
Poor quality and unreadable films were excluded through a consensus read determined 
during the data analysis phase. 
 
5.3	Study	period	
A period of 5 years spanning from 1 February 2009 to 31 December 2013.  
 
5.4.	Materials	and	Methods	
Chest X-rays (frontal and lateral) and patient information (age, HIV status) of all children 
enrolled in a larger study of TB diagnosis at the RCCH, with confirmed TB (on culture or 
Gene Xpert), from 1 February 2009 until 31 December 2013, were collected from an existing 
study database with permission from Professor Zar (Appendix 3), the lead investigator.  
Eighty-four control patients, who presented to RCCH with a lower respiratory tract infection 
other than TB (negative microbiological investigations for TB, not clinically diagnosed with 
TB, and improved at 3 months without TB treatment) were retrieved from the same 
research database.   
Each digital J-PEG CXR pair (frontal and ‘combined frontal-lateral’ CXR set) was randomly 
allocated a number from 1-172. Only the study author had a key to the patient details 
corresponding to the study number. 
The digital CXR files were saved onto 2 DVDs - the first DVD contained all the frontal X-rays, 
the second DVD all the ‘combination frontal-lateral’ CXR sets- and these were copied to 
yield 4 sets of two DVD’s (one for each reader and one back-up for the primary investigator). 
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The CXRs were labelled 1- 172 with no other patient information on the radiographs. Three 
qualified radiologists independently read the CXRs in 2 separate sittings (one the frontal X-
ray and one for the ‘combination frontal-lateral’ CXR set) one month apart, using their own 
DVD set, blinded to the diagnosis of PTB.  
The reading was performed on each reader’s personal computer. 
The readers were blinded to all clinical information (i.e. the diagnostic category) and to each 
other’s findings. 
The readers were required to complete a CRF for each CXR read – when reading the frontal 
x-rays they completed a single CRF (Appendix 1), when reading the ‘combination frontal-
lateral’ CXR set they were required to complete 2 CRFs (Appendix 1 and 2). The CRFs with 
potential lymph node enlargement were limited to the following criteria (as per Andronikou 
et al)(2, 20). 
The criteria for lymphadenopathy on frontal films: 
• The mediastinal outline appears multilobulated with or without 
mediastinal shift. 
• Filling of the hilar point: may manifest as obliteration of the hilar “V”, 
a convex margin of the hilar point, hilar elevation or a hilar mass. 
• Airway compression: caused by enlarged lymph nodes may result in 
complete or partial airway obstruction. Partial obstruction manifests 
as hyperinflation of a lobe distal to the obstruction as opposed to 
complete obstruction, which results in collapse (24).  
 
The criteria for lymphadenopathy on lateral films (20, 21): 
• The doughnut sign: a soft tissue lobulated density noted posterior and 
inferior to bronchus intermedius. The doughnut ring is completed by 
the main pulmonary arteries and the aortic arch. 
• The incomplete doughnut sign: A lobulated soft tissue mass anterior, 
inferior or posterior to bronchus intermedius.  
Readers underwent standardized training prior to reading. The principal investigator 
explained the CRF form to the readers who were then given 2 papers, describing the above 
lymphadenopathy features (19, 20), to read, in their own time, prior to beginning reading 
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the X-rays. They were also instructed to only record presence of lymphadenopathy when 
they had confidence in the feature of a sufficient degree to be able to demonstrate the 
lymphadenopathy on the image to an imaginary student. If any queries arose regarding the 
CRF or the two articles the principal investigator was available to clarify any questions.  
 
5.5.	Data	collection	and	collation	
Once the CRF forms were completed by all 3 readers, the principal investigator captured the 
results onto a Microsoft Excel spreadsheet. The principal investigator was responsible for 
quality assurance, and data collation. 
 
5.6.	Reliability	and	validity	
Three readers were used to read the X-rays in an attempt to increase reliability.  
Our study aimed to measure the diagnostic accuracy of CXRs for detecting 
lymphadenopathy in children to diagnose PTB. However the readers were not required to 
detect TB but rather the surrogate marker of this, which is lymphadenopathy. Therefore the 
detection of lymphadenopathy was evaluated against gene Xpert or culture positive TB. A 
control group of patients, with a LRTI other than TB, were used to increase validity. 
 
5.7.	Bias	
An element of omission bias was present due to the omission of poor quality CXRs, i.e. CXRs 
were excluded using the 3 readers consensus decision during the data analysis phase. 
 
6.	Data	analysis	and	statistics	
Data was analysed using Epi Info software, version 6.04d (Centers for Disease Control and 
Prevention, Atlanta, Georgia). 
Two by two tables were generated with Chi-squared test or Fisher’s exact tests as 
appropriate using the TB culture / Xpert as the “gold standard” and the frontal and 
‘combination frontal-lateral’ CXR consensus reading as the test (of lymphadenopathy). From 
these, prevalence rates for lymphadenopathy in each group were calculated. Odds ratios 
and 95% confidence intervals were derived where significant associations were observed. 
Statistical significance was set as a P-value of <0.05 as per standard practice. Kappa values 
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for inter reader agreement were calculated according to a study by Landis and Koch (29) in 
1977 and interpreted as follows: 
 
Table	2:	Interpretation	of	kappa	values	by	Landis	and	Koch	(29)	
Kappa Interpretation 
<0 Less than chance agreement 
0.01-0.2 Slight 
021-0.4 Fair 
0.41-0.6 Moderate 
0.61-0.8 Substantial 
0.81-0.99 Almost perfect 
1 Perfect agreement 
 
7.	Ethics	
Ethics approval for the overall parent study was from the Faculty of Health Sciences 
Research Ethics Committee, University of Cape Town (UCT.) Letters of permission were 
obtained from the head of RCCH paediatric unit (Appendix 3). 
Ethics approval for this study was granted by the University of Witwatersrand Human 
Research Ethics committee (certificate #: M140422- Appendix 4) 
No additional imaging was performed for the purposes of this study and CXRs already 
performed for clinical purposes were used.  
 
7.1.	Consent	forms	
Consent for use of the data was obtained from the principal investigator at RCCH. 
No consent forms were required for the study, as all patient personal information was kept 
confidential and this study was retrospective in nature, nested in the larger study. Consent 
for participation in the larger study, in which this one is nested, was obtained. 
 
7.2.	Data	safety	
The patient data was stored on the primary investigator’s computer with backup files saved 
onto an external hard drive. Data was collected anonymously by allocating a random 
number code to each patient. The key to this code was only available to the primary 
investigator and supervisor. 
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8.	Results:			
8.1	Demographics	and	baseline	characteristics	
One hundred and seventy two children were included (Figure 1 below), with a median age 
of 29 months, range of 2 months- 155 months, with an interquartile range (IQR) of 66.0 
months. 
Of the 172 children enrolled in the study, 88 (51%) were microbiologically confirmed to have 
TB  (median age 30 months, IQR= 62.25 months) while 84 (49%) were in the control group 
(median age 29 months, IQR = 70.5 months), p=0.50.  
Of the 88 patients with microbiologically confirmed TB, 15 (17%) were HIV positive and 73 
(83%) were HIV negative, p= 0.00. 
Of the 84 control cases 18 (21%) were HIV positive and 66 (79%) were HIV negative, p= 0.00. 
 
 
Figure	1.	Flow	diagram	illustrating	study	population	and	demographics	
 
8.2	Detection	of	lymphadenopathy	using	a	frontal	and	frontal-lateral	CXR	
combination	for	all	patients,	with	and	without	proven	PTB.	
The prevalence of lymphadenopathy on frontal CXR and the frontal-lateral CXR combination 
are described in table 3.1 below. 
All Patients 
N=172
Microbiologically 
proven TB
N=88 (51%)
HIV Infected.
N=15 (17%)
HIV Negative.
N=73 (83%)
Control group
N=84 (49%)
HIV Infected.
N=18 (21%)
HIV Negative.
N=66 (79%)
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For all children (N=172), frontal CXR lymphadenopathy was reported in 86 (50%) patients - 
of these, 52 (60%) had microbiologically proven TB and 34 (40%) were from the control 
group, p = 0.00. 
 Of the 86 (50%) patients with no lymphadenopathy 36 (42%) were TB proven and 50 (58%) 
were from the control group, p = 0.00. 
For all children (N=172), frontal-lateral CXR combination lymphadenopathy was reported in 
143 (83%) patients - of these 72 (50%) were microbiologically positive for TB and 71 (50%) 
were from the control group, P= 0.40. Of the 29 (17%) patients with no lymphadenopathy 
16 (55%) were microbiologically positive for TB and 13 (45%) were from the control group, 
P=0.34. 
 
Table	3.1:	Presence	of	lymphadenopathy	using	a	consensus	reading	on	a	frontal	CXR	only	
and	frontal-lateral	CXR	combination	according	to	final	diagnosis	of	TB		
 Frontal CXR Lymphadenopathy Frontal-lateral CXR 
Lymphadenopathy 
All patients. 
N=172 
86 (50%) 143 (83%) 
Microbiologically proven TB N=88 
(51%) 
52 (59%) 72 (82%) 
Control group N=84 (49%) 34 (40%) 71  (85%) 
 
8.3	Detection	of	lymphadenopathy	using	a	frontal	and	frontal-lateral	CXR	
combination	for	HIV	infected	and	HIV	negative	children.	
The prevalence of lymphadenopathy on frontal CXR and the frontal-lateral CXR combination 
in patients who were HIV infected and HIV negative are described in table 3.2 below. 
 
For the HIV infected children (N=33), frontal CXR lymphadenopathy was reported in 21 
(64%) patients, and in 28 (85%) of patients on the frontal-lateral CXR combination, p = 0.02. 
For the HIV negative children (N=139), frontal CXR lymphadenopathy was reported in 65 
(47%) patients, and in 115 (83%) patients on the frontal-lateral CXR combination, p = 0.00. 
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Table	3.2:	Presence	of	lymphadenopathy	using	a	consensus	reading	on	a	frontal	CXR	only	
and	frontal-lateral	CXR	combination	according	to	HIV	status	
 Frontal CXR lymphadenopathy Frontal-lateral CXR combination 
Lymphadenopathy 
All patients N=172 86 (50%) 143 (83%) 
HIV Infected N=33 (19%) 21  (64%) 28 (85%) 
HIV Negative N=139 (81%) 65 (47%) 115 (83%) 
 
8.4	Detection	of	lymphadenopathy	using	a	frontal	and	frontal-lateral	CXR	
combination	according	to	final	TB	diagnosis	and	stratified	by	HIV	status.	
For all children with microbiologically proven TB (N=88), 15 (17%) were HIV infected, of 
these lymphadenopathy was found in 13 (87%) patients on either the frontal or on the 
frontal-lateral CXR combination. In contrast of 73 (83%) HIV negative children, 
lymphadenopathy was found in 39 (53%) patients on the frontal CXR alone and in 59 (81%) 
patients on the frontal-lateral CXR combination, p = 0.00. 
For all children in the control group (N=84), 18 (21%) were HIV infected; of these 
lymphadenopathy was found in 8 (44%) patients on the frontal CXR alone and in 15 (83%) 
patients on the frontal-lateral CXR combination, p = 0.01. 
For all children in the control group (N=84), 66 (79%) were HIV negative; of these 
lymphadenopathy was found in 26 (39%) patients on the frontal CXR alone and in 56 (85%) 
patients on the frontal-lateral CXR combination, p = 0.00. 
 
These results are summarised in table 3.3 below. 
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Table	3.3	Presence	of	lymphadenopathy	using	a	consensus	reading	on	a	frontal	CXR	only	
and	frontal-lateral	CXR	combination	according	to	TB	diagnosis	and	stratified	by	HIV	
status 
TB diagnosis HIV status Frontal CXR 
lymphadenopathy 
Frontal-lateral CXR 
lymphadenopathy 
Microbiologically 
proven TB 
(N=88) 
HIV infected N=15 
(17%) 
13 (87%) 13 (87%) 
HIV negative N=73 
(83%) 
39 (53%) 59 (81%) 
Control group 
(N=84) 
HIV infected N=18 
(21%) 
8 (44%) 15 (83%) 
HIV negative N=66 
(79%) 
26 (39%) 56 (85%) 
 
8.5	CXR	findings	of	lymphadenopathy	using	frontal	vs	frontal-lateral	CXR	
combination	with	odds	ratios.	
The odds ratios for the presence of lymphadenopathy on frontal CXR and the frontal-lateral 
CXR combination are described in table 3.4 below. 
Evaluating all children, N=172, the consensus reading using a frontal-lateral CXR 
combination resulted in a 5-fold increase (OR 4,9; 95% CI 2,9-8,4) in calling 
lymphadenopathy compared to the readers’ consensus reading using a frontal CXR only.  
In the microbiologically proven TB group, N=88, the consensus reading using a frontal and 
lateral CXR combination resulted in a 3-fold increase (OR 3,1; 95% CI 1,5-6,6) in calling 
lymphadenopathy compared to the readers’ consensus reading using a frontal CXR only. 
In the control group, N=84, using a frontal and lateral CXR combination the consensus 
reading resulted in an 8-fold increase (OR 8; 95% CI 3,7-18,1) in calling lymphadenopathy 
compared to a readers’ consensus reading using a frontal CXR only. 
In the HIV negative group, N=139, the consensus reading using a frontal and lateral CXR 
combination resulted in a 5-fold increase (OR 5,4; 95% CI 3-9,9) in calling lymphadenopathy 
compared to a readers’ consensus reading using a frontal CXR only. 
In the HIV infected group, N=33, the consensus reading using a frontal and lateral CXR 
combination trended towards an increase in calling lymphadenopathy compared to a 
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readers’ consensus reading using a frontal CXR only however this increase was not 
statistically significant (OR 3,2; 95% CI 0,86-13,2). 
 
Table	3.4.	Presence	of	lymphadenopathy	using	frontal	vs	frontal-lateral	CXR	combination	
with	odds	ratios	
 Frontal and 
Lateral CXR 
(2nd read) 
Frontal CXR 
(1st read) 
Odds Ratios 
Overall 
N=172 (%N) 
143 (83%) 86 (50%) OR 4,9; 
(95% CI 2,9-8,4) 
HIV Infected 
N=33 (%N) 
28 (85%) 21 (64%) OR 3,2 
(95% CI 0,86-13,2) 
HIV Negative 
N=139 (%N) 
115 (83%) 65 (47%) OR 5,4 
(95% CI 3,0-9,9) 
Microbiologically 
proven TB 
N=88 (%N) 
72 (82%) 52 (59%) OR 3,1 
(95% CI 1,5-6,6) 
Control group 
N=84 (%N) 
71 (85%) 34 (40%) OR 8 
(95% CI 3,7-18,1) 
 
8.6	Inter	reader	agreement	in	detecting	lymphadenopathy	on	frontal	and	
frontal-lateral	CXR	combinations,	in	all	patients	and	stratified	by	TB	
diagnosis	and	HIV	status.	
Overall inter reader agreement for all 3 readers when evaluating for lymphadenopathy was 
fair on both the frontal CXR (Kappa=0,21) and the frontal-lateral CXR combination (Kappa= 
0,23). Table 3.5 further demonstrates inter reader agreement for patients with and without 
confirmed TB and HIV infected and HIV negative patients. Inter reader agreement in 
patients with microbiologically proven TB was fair on the frontal and frontal-lateral CXR 
combination (Kappa= 0,25 and Kappa=0,4 respectively) and slight in the control group on 
the frontal and frontal-lateral CXR combination (Kappa= 0,14 and Kappa= 0,09 respectively).  
Inter reader agreement in HIV infected patients was slight on both the frontal and frontal-
lateral CXR combination (Kappa= 0,14 and Kappa= 0,11 respectively) and fair in HIV negative 
patients (Kappa =0,22 and Kappa=0,25 respectively). 
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Table	3.5	Inter	reader	agreement	using	kappa	values	(K)	for	lymphadenopathy	for	the	
frontal	vs	the	frontal-lateral	CXR	combination. 
 3 reader inter reader agreement  
kappa values on the frontal CXR 
alone 
3 reader inter reader agreement  
kappa values on the frontal-
lateral CXR combination. 
All patients 0,21 0,23 
Microbiologically proven TB 0,25 0,4 
Control group 0,14 0,09 
HIV infected 0,14 0,11 
HIV negative 0,22 0,25 
 
 
8.7 Detection of lymphadenopathy per lymph node region using a frontal and 
frontal-lateral CXR combination. 
When further evaluating the data we found that the commonest site for reported 
lymphadenopathy (summarised in table 3.6) was the left hilum on the frontal CXR, first read.  
In contrast the right hilum was the commonest site on the frontal CXR, second read. On the 
lateral CXR the commonest reported site of lymphadenopathy was anterior to bronchus 
intermedius. 
The inter reader agreement for all children on reading the frontal CXRs was fair 
(Kappa=0,26) for first read where the left hilum was commonest, and (Kappa=0,24) for the 
second read where the commonest site was the right hilum. The inter-reader agreement for 
the commonest lymph node site reported on the lateral CXR, anterior to bronchus 
intermedius, was slight (Kappa=0,19). 
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Table	3.6:		Commonest	reported	sites	of	lymphadenopathy	using	a	consensus	reading	on	
frontal	and	frontal-lateral	CXR	combination.	
 Frontal CXR 1st read- 
commonest site for all 
demographics= left 
hilar 
Frontal CXR 2nd read 
Commonest site for all 
demographics= right 
hilar 
Lateral CXR 
Commonest site for all 
demographics= 
anterior to bronchus 
intermedius. 
All children N=172 (%) 69 (40%) 95 (55%) 133 (77%) 
HIV Infected N=33 (%) 17 (51%) 24 (73%) 27 (82%) 
HIV Negative N=139 
(%) 
52 (37%) 71 (51%) 106 (76%) 
Microbiologically 
proven TB N=88 (%) 
40 (45%) 46 (52%) 67 (76%) 
Control group N=84 
(%) 
29 (35%) 49 (58%) 66 (79%) 
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9.	Discussion:	
9.1.	Value	of	the	addition	of	a	lateral	CXR	to	the	standard	frontal	CXR	for	
diagnosing	lymphadenopathy.	
This study aimed to determine the value of lateral radiographs for the diagnosis of 
lymphadenopathy in children with pulmonary TB. Lymphadenopathy is the hallmark of 
pulmonary TB in children (10, 15-17). A CXR is frequently used to confirm the diagnosis of TB 
and thus guide appropriate management of the child. 
 
This study found that the addition of a lateral view to the standard frontal CXR increased the 
rate of diagnosis of lymphadenopathy, however the prevalence of lymphadenopathy was 
similar in children with PTB and those in the control group, with fair inter reader agreement. 
 
Overall, the frontal-lateral CXR combination resulted in an almost 5- fold (OR 4,9 CI: 2,9-8,4) 
increase in reporting lymphadenopathy than did the frontal CXR alone; with an increase of 
33% with the addition of the lateral CXR (50% of patients had lymphadenopathy on frontal 
CXR and 83% had lymphadenopathy on the frontal-lateral CXR combination). 
 
Table 4.1 below summarises and compares the findings of our study with the findings of 
other prior similar studies. Our findings are comparable to a study by Smuts et al (24) from 
1994 which advocates the use of a combination frontal-lateral CXR to diagnose 
lymphadenopathy in children with TB. In their study the presence of reported 
lymphadenopathy more than doubled with the addition of a lateral CXR, from 7% to 18%. 
This increase in reporting lymphadenopathy was most prominently reported in cases of 
confirmed TB, with no new cases of lymphadenopathy seen in patients with no TB. In our 
study a 3-fold increase (59% to 82%) was observed with the addition of the lateral CXR in 
patients with confirmed TB. In contrast to the study by Smuts et al the most significant 
increase in reporting lymphadenopathy with the addition of the lateral CXR was seen in 
patients who did not have TB (40% to 85%). 
A study by Swingler et al (18) however reported that the addition of a lateral CXR shows a 
‘non significant trend towards an increased OR than the use of the AP X-ray alone’. 
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Table	4.1:	Summary	of	relevant	studies	comparing	findings	on	lateral	and	frontal	CXRs	
Study Patients Frontal CXR 
lymphadenopathy 
Frontal and lateral 
CXR combination 
lymphadenopathy. 
Conclusions: Differences to 
our study: 
Our Study 
2017 
Confirmed 
TB 
N=88 
52 (59%) 72 (82%) The addition of a 
lateral view to the 
standard frontal 
CXR increased the 
rate of calling 
lymphadenopathy. 
However this 
increase also 
occurred in 
the TB 
negative group 
Control 
group 
N=84 
34 (40%) 71 (85%) 
Smuts et al 
1994 
Confirmed 
TB N=176 
19 (11%) 40 (23%) The lateral CXR is 
needed in 
conjunction with 
the frontal CXR to 
diagnose LAD in 
children with PTB. 
The X-rays 
were read by 1 
paediatric 
pulmonologist 
and multiple 
paediatricians. 
No TB N=133 2 (1,5%) 2 (1,5%) 
Swingler et 
al 
(2005) 
Suspected 
TB N=100 
Diagnostic OR 3,1 Diagnostic OR 3,7  Reference 
standard for 
LAD was spiral 
CT. 
XRs read by 
primary care 
physicians and 
paediatricians 
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9.2.	Interpretation	of	the	presence	of	lymphadenopathy	per	location.	
Further evaluation of our data found that the commonest lymphadenopathy sites reported 
by the readers were the hilar nodes on the frontal CXR (left hilar on the first read and right 
hilar on the second read) and anterior to bronchus intermedius on the lateral CXR. As 
described in the literature, anatomically there are more lymph nodes (in number) in the 
paratracheal regions, however hilar lymphadenopathy is more commonly visualised on 
frontal CXR (24). This is mirrored in our study where hilar lymphadenopathy were the 
commonest sites reported as being present. 
 
9.3	Inter-reader	agreement	in	evaluating	lymphadenopathy	with	the	
addition	of	a	lateral	CXR	to	the	standard	frontal	lateral	combination.		
Overall agreement remained fair when evaluating for lymphadenopathy in all patients on 
the frontal CXR (Kappa=0,2088) and the frontal-lateral CXR combination (Kappa= 0,233), and 
in the HIV negative patients (Kappa =0,219 on the frontal CXR and Kappa=0,252 on the 
frontal-lateral CXR combination) 
In the HIV infected group agreement remained slight on both the frontal  (Kappa=0,1403) 
and frontal- lateral CXR combination (Kappa=0,113). 
 
This raises 3 questions:  
1) Was the training received by the 3 readers adequate? 
All 3 readers received the same training through 2 thorough articles which adequately 
addressed the radiological evaluation of lymphadenopathy on paediatric CXRs- however no 
test cases were provided to the readers to confirm they understood the directions given. 
Two of the three readers were qualified (One was fellowship trained and the other is head 
of a children’s hospital radiology department) paediatric radiologists practising in South 
Africa - where there is sufficient experience diagnosing primary TB - and thus level of 
expertise should not have played a role in the poor inter reader agreement. 
 
2) Why was the prevalence of lymphadenopathy similar in children with PTB and those in 
the control group? 
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There are two possible explanations for this: 
A) All children in our study population had LRTIs and over and above this some were HIV 
infected- therefore the prevalence of these patient’s having lymphadenopathy maybe 
higher than the general population even if they do not have PTB. 
This finding is consistent with our suboptimal inter reader agreement, which was overall 
‘fair’ between readers and only slightly better when using a frontal-lateral combination 
(Kappa=0,23) compared to the frontal CXR alone (Kappa=0,21). These findings are consistent 
with similar studies by Swingler et al (18) and du Toit et al (12) (see table 4.2) which both 
demonstrated only fair inter reader agreement, with Kappa of 0,36 and 0,33 respectively, 
when assessing for lymphadenopathy on CXR. The study by Swingler et al (18) further 
confirmed that the inter reader agreement was similar for the frontal CXR alone and the 
frontal-lateral CXR combination but decreased when the lateral CXR was read in isolation. 
Despite CT being the gold standard in diagnosing mediastinal and hilar lymphadenopathy, 
only moderate inter reader agreement was found in a study by Andronikou et al (22). This 
was however performed on older CT technology and did not specify any size or 
characteristic criteria for distinguishing lymphadenopathy from ‘normal’ lymph glands in the 
mediastinum (22). 
The poor inter reader agreement demonstrated by our study is likely due to the lack of  
criteria for defining lymphadenopathy and the intrinsic limitations of CXR.  Radiographs are 
a 2 tone (either black or white) summation image of a 3 dimensional body with multiple 
anatomical overlying shadows which may obscure underlying lymphadenopathy. 
Furthermore, parenchymal pathology and lymphadenopathy both appear radiopaque on 
radiography and thus lymphadenopathy may be obscured by underlying parenchymal 
disease (28). 
 
Figure 2.1a and 2.1b below are examples of a frontal and frontal-lateral CXR combination 
from this study which demonstrated good inter-reader agreement; all three readers agreed 
that lymphadenopathy was present on the frontal CXR and the frontal and lateral CXR 
combination. This patient was microbiologically proven to have TB and was HIV infected. All 
3 readers agreed that there was bilateral hilar lymphadenopathy, however they did not 
agree on whether there was mediastinal lymphadenopathy or not. All 3 readers agreed that 
there was lymphadenopathy on the lateral CXR with only 2 reporting the full donut sign.  
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Figure	2.1a:	Frontal	CXR	of	a	child	with	microbiologically	confirmed	TB	and	HIV	infected	
where	all	3	readers	reported	lymphadenopathy	
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Figure	2.1b:	Lateral	CXR	of	a	child	with	microbiologically	confirmed	TB	and	HIV	infected	
where	all	3	readers	reported	lymphadenopathy	
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Figures 2.2a and 2.2b below are examples of a frontal and frontal-lateral CXR combination 
from this study that demonstrated poor inter-reader agreement. Reader 1 reported 
lymphadenopathy in all stations on both frontal and lateral CXRs on both reads. Reader 2 
reported lymphadenopathy on the frontal-lateral CXR combination but not on the frontal 
CXR when read alone. Reader 3 reported lymphadenopathy on the frontal CXR on the first 
read but no lymphadenopathy when reading the frontal-lateral CXR combination.  
Readers 2 and 3 described the left mediastinal region as ‘area obscured by parenchymal 
disease’ whereas reader one described the opacity as lymphadenopathy. This further 
confirms the limitation of the 2 tone nature (i.e. either black or white) of plain film 
radiography; lymphadenopathy, vascular structures and parenchymal pathology all appear 
radiopaque on CXRs and thus accurate delineation of these structures can be difficult even 
for the experienced radiologist. This patient was HIV negative but had microbiologically 
proven TB.  
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Figure	2.2a:	Frontal	CXR	of	an	HIV	negative	child	with	microbiologically	proven	TB	where	
there	was	poor	inter	reader	agreement	on	the	presence	of	lymphadenopathy.	The	left	
hilum	is	obscured	by	adjacent	air-space	disease	but	the	left	main	bronchus	compressions	
suggests	that	there	is	indeed	left	hilar	lymphadenopathy	present.	There	is	also	a	diffuse	
nodular	pattern	in	keeping	with	miliary	TB	as	well	as	a	right-sided	lamellar	effusion.	
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Figure	2.2b:	Lateral	CXR	of	an	HIV	negative	child	with	microbiologically	proven	TB,	
where	there	was	poor	inter	reader	agreement	on	the	presence	of	lymphadenopathy.	
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Table	4.2:	Summary	of	relevant	studies	comparing	inter	reader	agreement	in	reading	
CXRs	
Study: Objective relative to 
our study 
Inter reader agreement Other: 
Du Toit et al 2002 Assess inter reader 
agreement in detecting 
lymphadenopathy in 
children at risk for TB 
Average weighted 
kappa=0,33 
CXRs read by paediatric 
pulmonologists Caution 
is necessary when 
basing clinical decisions 
on presence of 
lymphadenopathy on 
CXR 
Swingler et al 2005 Diagnostic accuracy of 
CXR in detection of 
chest lymphadenopathy 
in kids with suspected 
pulmonary TB 
Inter reader agreement 
kappa=0,36. 
 
Agreement was similar 
for AP views alone and 
AP and lateral views 
together but less good 
for lateral views alone. 
Andronikou et al 2004 Inter reader variability 
for detecting hilar and 
mediastinal 
lymphadenopathy on CT 
Overall kappa=0,6 
 
R hilar>Subcarinal>R 
paratracheal 
 
3) What is the correct reference standard for diagnosing lymphadenopathy? 
The reference standard for lymphadenopathy should not be microbiological confirmation 
Xpert, but rather contrast enhanced CT of the chest (25)- this is emphasised by the results of 
a study by Delacourt et al (27) in 1993 which detected lymphadenopathy on CT scan in 60% 
of their study patients who had normal CXRs. However even CT scan is lacking in that there 
is no predefined size criteria for distinguishing lymphadenopathy from non-pathological 
lymph glands in the chest in children (22). 
 
9.4	Evaluation	of	lymphadenopathy	according	to	HIV	status.	
To the best of our knowledge our study is unique in that we further evaluated for the 
presence of lymphadenopathy according to the patients HIV status.  
In both the HIV infected and HIV negative groups there was an increase in diagnosis of 
lymphadenopathy with the addition of a lateral CXR.  
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Surprisingly the increase was more in the HIV negative group which reported a 5 fold 
increase in lymphadenopathy versus a 3 fold increase in the HIV positive group. 
 
9.5	Limitations	of	the	study.	
Despite the readers being given 2 articles describing the interpretation of CXRs with regards 
to lymphadenopathy, no clearly defined criteria for the diagnosis of lymphadenopathy were 
provided. Furthermore no test cases were provided to the readers to confirm if they 
understood the directions given. 
This is reflected in our results which demonstrate the presence of lymphadenopathy in 83% 
of patients, with almost 50% of patients being in TB negative groups.  
 
The images used in this study were JPEG, rather than DICOM, which are of inferior quality 
making interpretation more difficult.  
 
In our study the reference standard for lymphadenopathy was a positive microbiological 
result and no correlation was made with the gold standard of diagnosing lymphadenopathy 
(CT scan) to actually confirm presence of nodes. However radiation dose concerns precludes 
performing CT scans as the gold standard for lymphadenopathy in children. 
 
Our study did not fully explore the role of HIV in the manifestations of thoracic TB or other 
lower respiratory tract infections. No correlation with patient’s CD4 count or antiretroviral 
therapy was done which may result in lymphadenopathy being reported which is not due to 
TB. Other opportunistic LRTIs manifest with mediastinal nodes but are much smaller than 
nodes caused by TB and are thus not appreciated on CXRs. In current clinical practice 
patients are suspected to have TB, diagnosed on CXRs, whether they have PTB or 
pneumonia, irrespective of their HIV status. 
 
9.6	Areas	of	future	research	identified	by	the	current	study.	
A future research project can be proposed as a consequence of this study to correlate the 
presence of lymphadenopathy on CXR not only with the microbiological results but with a 
CT scan. This will allow further understanding of the different spectrum of TB changes in HIV 
infected and negative children. Confirmation of lymphadenopathy on CT scan can 
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furthermore be used to assess the interpretation of the CXR and thus recommend better 
criteria for diagnosing lymphadenopathy on CXR. Additionally with CT scan confirmation of 
lymphadenopathy the cause for the poor inter reader agreement can be evaluated. 
A pilot study done by Moseme et al (30) evaluated ultrasound as a means for assessing 
anterior mediastinal lymphadenopathy; they found that ultrasound through the 
suprasternal notch is reliable in diagnosing mediastinal lymphadenopathy in children with 
supposed TB. This was a pilot study however with only 30 children in the study population. 
Further studies evaluating the usefulness of mediastinal ultrasound in diagnosing 
lymphadenopathy in children with TB may present an accessible, no radiation, means for 
diagnosis and follow up in these patients. Thus a study comparing CXRs, CT and ultrasound  
to assess for lymphadenopathy as a marker for TB in children is an area for future research. 
 
10.	Conclusion:	
The addition of a lateral view to the standard frontal CXR increased detection of 
lymphadenopathy, however, the prevalence of lymphadenopathy was similar in children 
with PTB and those in the control group, with fair inter reader agreement. 
Our findings are in keeping with other studies that highlight the weakness of CXR for 
diagnosing primary PTB in children and we recommend that future research aim at 
comparing radiographs with CT cross sectional imaging to determine the true accuracy of 
this imaging technique for detecting lymphadenopathy. If these also demonstrate poor 
accuracy, then the widespread use of X-ray for diagnosing primary in TB needs to be 
challenged and novel diagnostic imaging tests such as mediastinal ultrasound, low dose 
chest CT or MRI need to be introduced depending on the available resources. 
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